Evaluating the Virus Neutralizing Effect of SARS-CoV-2 Neutralizing Antibodies Developed by Constructing Highly Diverse Antibody Libraries from Indian Population using Phage Display Technology
40th Annual meeting of European Society for Paediatric Infectious Diseases (ESPID)
Evaluating the Virus Neutralizing Effect of SARS-CoV-2 Neutralizing Antibodies Developed by Constructing Highly Diverse Antibody Libraries from Indian Population using Phage Display Technology
Developing safe, effective and affordable Bi-antigen SARS-CoV-2 Vaccine candidate comprising S1 subunit and N protein expressed in Pichia pastoris for the Developing Countries
Biotherapeutics and Vaccines Development Gordon Research Conference
A Bi-Antigen Recombinant Subunit SARS-CoV-2 Vaccine consisting of S1 Subunit and N protein, expressed in Pichia pastoris: A Safe, Effective and Affordable Candidate Designed for Low- and Middle-Income Countries
Development of SARS-CoV-2 Neutralizing Antibodies by Constructing Highly Diverse Antibody Libraries from Indian Population using Phage Display Technology
A Bi-Antigen Recombinant Subunit SARS-CoV-2 Vaccine comprising S1 Subunit and N protein expressed in Pichia pastoris: A Low-cost, Safe and Effective Candidate for Low- and Middle-Income Countries.
International Conference on Biotechnology and Biological Sciences Biospectrum 2021
Developing safe, effective and affordable Multiantigen SARS-CoV-2 Vaccine comprising S1, S2, M and N protein expressed in Pichia pastoris for Low-and-Middle Income Countries
18th Asia Pacific Congress of Clinical Microbiology and Infection
A Bi-Antigen Recombinant Subunit SARS-Cov-2 Vaccine Comprising S1 Subunit and N Protein Expressed In Pichia Pastoris: A Low-Cost, Safe And Effective Candidate For Low- And Middle-Income Countries
International Conference on Infections and Immunity
A Bi-Antigen Recombinant Subunit SARS-CoV-2 Vaccine comprising S1 Subunit and N protein, expressed in Pichia pastoris: A Low-cost, Safe and Effective Candidate Designed for Developing Countries
Developing Low-cost, Safe and Effective Bi-antigen SARS-CoV-2 Vaccine comprising S1 subunit and N protein expressed in Pichia pastoris for Developing Countries
2021 International Society of Vaccines Annual Conference